Navigation Links
Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
Date:9/1/2013

AMSTERDAM, The Netherlands and OSAKA, Japan, Sept. 2, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) today announced results of the EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) cardiovascular (CV) safety outcomes trial, showing the primary endpoint of non-inferiority compared to placebo in addition to standard of care was met with no increase in CV risk in a Type 2 diabetes patient population at high-risk for CV events. These data, published in the New England Journal of Medicine (NEJM) and also presented at the ESC Congress 2013, demonstrate that alogliptin does not increase CV risk in Type 2 diabetes patients at high-risk for major adverse cardiac events (MACE) due to a recent acute coronary syndrome (ACS). The trial's primary objective was to evaluate non-inferiority of CV risk based on a primary composite endpoint of CV death, nonfatal myocardial infarction and nonfatal stroke. The primary endpoint occurred at similar rates in the alogliptin and placebo groups (in 11.3% of patients vs. 11.8% of patients during a median follow-up period of 18 months; hazard ratio, 0.96; one-sided repeated confidence interval [CI] bound, 1.16). Alogliptin is a dipeptidyl peptidase-4 inhibitor (DPP-4i) for the treatment of Type 2 diabetes in adults to improve glycemic control as an adjunct to diet and exercise.

"There is a need for safer glucose lowering therapies in patients with diabetes who are at an elevated risk for cardiovascular disease," stated William B. White, MD, FASH, FAHA, FACP, principal investigator of the EXAMINE trial. "Given the EXAMINE study design and high-risk patient population evaluated, these results provide key insights to clinicians treating diabetes patients with coronary disease."

The global EXAMINE trial is an im
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimers Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
2. Takeda Launches New Subsidiary in Peru
3. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
4. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
5. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
6. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
7. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
8. Takeda to Acquire Inviragen, Inc.
9. Takeda Responds to Verdict in Diabetes Drug Case
10. Takeda Launches New Subsidiary in Ecuador
11. Takeda lanza nueva subsidiaria en Ecuador
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 ... the U.S. commercial launch of its foot plating system ... Paragon 28.  The GORILLA TM R3CON PLATING SYSTEM ... the Monster TM & Mini-Monster TM Screw ... Comprised of 10 interchangeable subsystems, the GORILLA TM ...
(Date:9/22/2014)... Sept. 22, 2014 The western European ... It is largely a replacement market with fewer ... mergers, acquisitions and partnerships are redefining competitive landscape ... research service provides details about revenue forecasts, unit ... trends across the country. The changing landscape makes ...
(Date:9/22/2014)... 2014 ... the addition of the  "Global Freeze Drying ... Market - Forecast to 2019"  report to ... ,The global freeze drying market was valued ... expected to reach at $2,655.9 million by ...
Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3
... 4, 2011 Reportlinker.com announces that a new market ... Personalized Medicine - scientific & commercial aspects ... aim of personalized medicine or individualized treatment is to ... in some cases, even to design the appropriate treatment ...
... a proposed Settlement in a class action lawsuit involving ... treat a variety of medical conditions including: cancer, HIV, ... blood issues, and many other conditions.  These drugs are ... This lawsuit is not about whether these drugs ...
Cached Medicine Technology:Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 2Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 3Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 4Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement 2
(Date:9/22/2014)... ARBOR, Mich. A surprising new study pulls back ... in health care: differences in payment and income between ... who don,t. , Contrary to perception, the research ... to favor surgeons and other procedure-performing doctors. , The ... simple difference in pay per minute explains why doctors ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... parents are aware of online physician-rating sites, and more than ... children, according to a new national study. The findings ... further suggest that negative online ratings may dissuade parents from ... by a neighbor. Conversely, a positive online rating may ...
(Date:9/22/2014)... (September 22, 2014) South Asians living in Canada ... the rate of diabetes compared with while people, McMaster ... today in the Canadian Medical Association Journal (CMAJ ... , One of the fastest-growing ethnic groups in ... Asian people living in Canada, comprising about three percent ...
(Date:9/22/2014)... September 22, 2014. Kessler researchers have published a ... psychoeducational wellness program in people with multiple sclerosis ... mental health, perceived stress, and pain. "Development ... individuals living with MS: Description and outcomes" was ... the International Journal of MS Care ...
(Date:9/22/2014)... Two new prescription devices approved by the U.S. Food ... people with migraine headaches who don,t tolerate migraine medications ... -- the Cefaly -- is designed to prevent migraines, ... meant to be used when migraines first start, according ... looking for alternative migraine treatments. Because these devices aren,t ...
Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2
... Feb. 16 (HealthDay News) -- Many American parents of children ... medicines to their kids despite U.S. Food and Drug Administration ... to research linking over-the-counter (or OTC) cough and cold medicines ... years and younger, the FDA said in 2008 that the ...
... A University of Minnesota research team was recently ... from the National Science Foundation,s Cyber-Enabled Discovery and ... vision algorithms that will assist with the early ... such as autism, attention deficit disorder (ADD) and ...
... TORONTO, Ont., February 16, 2011 One in five homeless ... according to a study led by St. Michael,s Hospital,s Dr. ... decade despite recommendations calling for greater improvements in prevention and ... inquest into the death of Joseph Teigesser, a homeless man ...
... Researchers from Indiana University-Purdue University Indianapolis (U.S.A) and Umea ... February 15, 2011, issue of PLoS Biology ... their DNA, known as Break-induced Replication (BIR), is up ... than normal cell repair. Accurate transmission of genetic ...
... Spanish provinces in terms of early prevention of breast cancer, ... rates, although the trend is towards the figures levelling out ... carried out by Spanish researchers, which analyses the number of ... Islands, Balearic Islands, some parts of Catalonia, Valencia and Murcia, ...
... radiation treatments for head and neck cancer fare significantly ... to a study in the February issue of the ... journal of the American Society for Radiation Oncology (ASTRO). ... and head and neck cancers has long been established, ...
Cached Medicine News:Health News:Parents Still Giving Cough, Cold Meds to Kids Under 2: Poll 2Health News:University of Minnesota researchers study the use of computer vision to diagnose mental disorders 2Health News:Death rate from tuberculosis in homeless alarmingly high: Study 2Health News:Method of DNA repair linked to higher likelihood of genetic mutation 2Health News:Study looks into evolution of breast cancer in Spain 2Health News:Smoking during radiation treatments reduces chance of overall survival 2
... Preserve your data for future generations. Most gels ... solid backing plate of our gel dryer, covering ... frame over them to hold the cellophane flat. ... frame with an open area somewhat larger than ...
... for future generations. Most gels can be dried ... of our gel dryer, covering them with wet ... to hold the cellophane flat. Tut's Tombs also ... open area somewhat larger than the gel to ...
... Slim Slab Gel Dryer accommodates large sequencing gels or ... TEFLON coated platen for long lasting durability and corrosion ... , Quick Drying Rate - large ... , Digital display of temperature and time ...
... gel dryer and oil-free vacuum pump into one ... setup. The extremely versatile gel drying system can ... and multiple mini-gels as well as drying large ... Completely Integrated Gel Drying System eliminates setup ...
Medicine Products: